1 December 2008
Amsterdam, The Netherlands -- A study published in the November issue of the Journal of Alzheimer’s Disease provides an insight into normal, physiological levels and association between proteins involved in development of Alzheimer’s disease.
24 November 2008
Amsterdam, The Netherlands and Sun City, AZ, USA -- A study published in the November issue of the Journal of Alzheimer’s Disease (Volume 15:3) suggests the reliability of the Alzheimer’s Disease Assessment Scale – Cognitive (ADAS-Cog) may vary and possess
17 November 2008
Atlanta—With millions of baby boomers entering late adulthood, the number of patients with Alzheimer’s disease (AD) is expected to drastically rise over the next several decades.
22 October 2008
Amsterdam – The past 25 years have seen an explosion of scientific investigations into the basic neurobiology of Alzheimer's disease (AD). Unfortunately, the gap between bench and bedside remains as vast as ever.
8 September 2008
Study is first to show obesity can cause neurodegeneration
28 July 2008
Amsterdam, The Netherlands and San Antonio, TX, USA — International publisher IOS Press and the Editors-in-Chief of the Journal of Alzheimer’s Disease (JAD) are pleased to announce a significant increase in the Journal’s Impact Factor, from 3.058
22 May 2008
Amsterdam — A number of chronic diseases are in fact caused by one or more infectious agents.
28 April 2008
Milan Fiala, MD, UCLA Orthopedic Hospital, has been chosen as the recipient of the 2008 Alzheimer Award presented by the Journal of Alzheimer’s Disease in recognition of his outstanding work, "Phagocytosis of amyloid-beta and inflammation: Two faces of inn
28 April 2008
An article published in the April issue of the Journal of Alzheimer’s Disease presents a detailed characterization of a new drug discovery tool for Alzheimer's disease. It demonstrates that an abnormal form of tau protein, as it occurs in Alzheimer's dise
9 April 2008
New research shows neuroprotective effect of lovastatin slows progression of Alzheimer's disease, among other benefits
High cholesterol levels are considered to be a risk factor for cardiovascular disease including stroke. Therefore, many cholesterol lowering drugs have been developed by pharmaceutical companies in recent years.